Dose: 0.035 to 0.285 mg/kg
Single Dose: 0.16 (0.16)
Frequency: 24 hourly
Route: IM
Instructions: -

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Piperidine. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Antiparkinson Agents pharmacological group.The Molecular Weight of Biperiden (HCl) is 347.90.

Biperiden (HCl) is contraindicated in conditions like Tardive dyskinesias,Cardiac dysrhythmias.

The severe or irreversible adverse effects of Biperiden (HCl), which give rise to further complications include Toxic confusional state.Biperiden (HCl) produces potentially life-threatening effects which include Cardiac arrhythmias. which are responsible for the discontinuation of Biperiden (HCl) therapy.The signs and symptoms that are produced after the acute overdosage of Biperiden (HCl) include Flushing, Tachycardia, Dilated pupils, Dry mucous membrane, Dry skin.The symptomatic adverse reactions produced by Biperiden (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Dry mouth, GI symptoms.

Biperiden (HCl) is primarily indicated in conditions like Acute dystonic reactions, Oculogyric crises, Parkinsonism, Pseudo-parkinsonism.

No data regarding the interactions of Biperiden (HCl) was found.

Drug should not be given to Paediatrics, Pregnant Mothers, Cardiac / Hypertensive Patients, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj Store Below 40°C. Do not Freeze. Protect from Sunlight and Moisture. Tab Store in a well closed container, Below 40°C. Protect from Moisture.

Biperiden should be used with caution in patients with heart, liver, kidney or obstructive gastrointestinal (GI) diseases. Patient should observe caution while driving or performing other tasks requiring alertness because may impair mental or physical abilities. It should be used with caution in hot weather. Reduce dose or discontinue therapy if loss of appetite or weight occur.